Johnson & Johnson snaps six straight days of gains

Johnson & Johnson (NYSE:JNJ) shares traded in the red on Monday, snapping six consecutive days of gains. The stock closed down 1.38% at $162.84.

JNJ stock rose about 6.6% in the last 12 months. YTD, the stock is trading up 4%, compared to the broader S&P 500 market which is up 23%.

Looking at Seeking Alpha’s Quant Ratings, this company has a Hold rating with a score of 3.27 out of 5.

When it comes to Wall Street analysis, 13 out of 23 analysts recommend a Hold, 7 recommend a Strong Buy and 3 recommend it as a Buy.

According to SA analyst Biologics, “New growth opportunities in oncology and MedTech segments, along with strategic acquisitions, are expected to offset potential declines in STELARA sales due to generics.”

Seeking Alpha analysts have a Buy rating on the company.